Open AccessAKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19
Author(s) -
Shruti Gupta,
Steven G. Coca,
Lili Chan,
Michal L. Melamed,
Samantha K. Brenner,
Salim S. Hayek,
Anne Sutherland,
Sonika Puri,
Anand Srivastava,
Amanda K. LeonbergYoo,
Alexandre M. Shehata,
Jennifer E. Flythe,
Arash Rashidi,
Edward J. Schenck,
Nitender Goyal,
S. Susan Hedayati,
Rajany Dy,
Anip Bansal,
Ambarish M. Athavale,
H. Bryant Nguyen,
Anitha Vijayan,
David M. Charytan,
Carl Schulze,
Min Joo,
Allon N. Friedman,
Jingjing Zhang,
Marie Anne Sosa,
Eric Judd,
Juan Carlos Q. Velez,
Mary Mallappallil,
Roberta E. Redfern,
Amar D. Bansal,
Javier A. Neyra,
Kathleen D. Liu,
Amanda D. Renaghan,
Marta Christov,
Miklos Z. Molnar,
Shreyak Sharma,
Omer Kamal,
Jeffery Boateng,
Samuel A.P. Short,
Andrew J. Admon,
Meghan E. Sise,
Wei Wang,
Chirag R. Parikh,
David E. Leaf
Publication year - 2020
Publication title -
journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.451
H-Index - 279
eISSN - 1533-3450
pISSN - 1046-6673
DOI - 10.1681/asn.2020060897
Subject(s) - medicine , renal replacement therapy , acute kidney injury , oliguria , intensive care medicine , intensive care , severity of illness , logistic regression , emergency medicine , pediatrics , renal function
AKI is a common sequela of coronavirus disease 2019 (COVID-19). However, few studies have focused on AKI treated with RRT (AKI-RRT).